Carnitine Supplements Market

Carnitine Supplements Market Value And Growth (2023-2028):

Carnitine Supplements Market was worth US$ 192 million in 2023 and is anticipated to reach a valuation of US$ 274 million by 2028 with a CAGR of 5%.

Carnitine Supplements Market Overview:

Over the forecast period, from 2022 to 2027, the worldwide carnitine supplements market share is expected to rise due to a growing concern about health among the older population, as well as an increased tendency toward preventive healthcare. L-carnitine is considered a component that can help the elderly recover faster after exercise. This substance also aids in the improvement of mental function and the reduction of fatigue in the elderly. Furthermore, it lowers the risk of skeletal degeneration, which affects the majority of the elderly population. These supplements aid in the prevention of muscle breakdown, the promotion of healthy aging, and the preservation of lean muscle mass. The worldwide carnitine supplement market growth is expected to increase significantly in the next years as a result of these advantages. L-carnitine products are also used to provide supplements to people who have a low amount of natural L-carnitine. The deficiency of L-carnitine is thought to be caused by a number of reasons, including certain medical illnesses such as skeletal myopathies, the use of particular medicines, and hereditary problems. In the coming years, these variables are expected to aid the demand for L-carnitine supplements.

Recent Developments in the Carnitine Supplements Industry:

• In October 2019, Lonza has introduced its new MuscleGuardTM formulation, a patent-pending ingredient combination that includes a clinically studied ratio of four nutrients, including Lonza's Carnipure L-Carnitine, Creatine, and Leucine, as well as vitamin D. Improvements in muscle strength, activity, and bulk are among the benefits of the solution for recuperation and sports performance.

• In April 2019, The BioContinuum buffer delivery platform, a new building piece of Merck's BioContinuum Platform for next-generation bioprocessing, was unveiled. It is an excellent product for more efficient buffer delivery and delivers accuracy and reliability and precision in buffer preparation.

REPORT COVERAGE:

Carnitine Supplements Market Drivers:

Growing usage of L-carnitine in the feed industry and higher demand for sport food products are projected to drive growth in the global carnitine supplements market.

The development of various improved l-carnitine supplements is another factor expected to contribute to the market's expansion. L-Carnitine Supplement is a dietary compensation used to supplement the body's lack of L-Carnitine. L-Carnitine is an amino acid that aids in the conversion of fat to energy and can also be used to treat cardiovascular problems. The global Carnitine Supplements Market volume has been driven by rising consumer knowledge of product benefits and increased use of the product in animal feed. For example, Rabie et al. discovered that feeding broiler chicks a diet supplemented with L-carnitine from 20 to 60 mg/kg increased their growth performance. Similarly, supplementing the diet with animal fat and 300 mg/kg of L-carnitine increased body weight gain, feed intake, and feed conversion efficiency in broiler chickens. Furthermore, rising consumption of functional foods is expected to improve the Global L-Carnitine Supplements Market's size.

Carnitine Supplements Market Restraints:

Excessive usage of l-carnitine supplements, on the other hand, can cause nausea, vomiting, stomach distress, diarrhoea, heartburn, and seizures. This could be a significant restraint on the global carnitine supplements market expansion over the next few years.

Carnitine Supplements Market Regional Analysis: 

The Global Carnitine Supplements Market Report includes the segmentation of Regions:

• North America

1. The U.S.

2. Canada

3. Mexico

The United States continues to have the largest proportion of the L-carnitine supplement market:

The United States is the world's third-largest biopharmaceutical market and a leader in biopharmaceutical research and development. The growth of the US pharmaceutical and biopharmaceutical industries is predicted to boost the use of lucarnitine in medications to prevent diabetes, thyroid illness, high blood pressure, and coronary artery disease.

Because of the increasing prevalence of various health conditions and obesity in the United States, the global market for carnitine supplements is predicted to rise rapidly in the years 2022-2027, resulting in higher demand in the region. Obesity-related diseases such as heart disease, hypertension, stroke, and diabetes are on the rise, which could enhance market growth in the region from 2022 to 2027.

Carnitine has been found to be an important component in the treatment and prevention of a variety of ailments, making it a desirable functional food and beverage ingredient. Consumers are placing a greater emphasis on functional foods and beverages containing lucarnitine as a result of increased energy and stamina, as well as other health benefits. Increasing consumer dependence on carnitine supplements in the North American region is expected to push market growth during the forecast period. Dietary supplements containing L-carnitine are also used to help people lose weight in the treatment of obesity. Because Mexico and the United States have the world's greatest obese populations, the use of dietary supplements to prevent weight gain is on the rise. Over the projection period, it is anticipated to remain to drive the regional market.

• Europe

1. The U.K.

2. France

3. Germany

4. Spain

5. Russia

6. Italy

In the market for global carnitine supplements, Europe is expected to be the leading market. Increased purchasing of dietary supplements as a preventative approach to health concerns are predicted to strengthen the European dietary supplement business. Furthermore, because of the potential for adverse effects, people choose herbal products to pharmaceuticals. Over the forecast period, increasing usage of dietary supplements to promote health without potential dangers is expected to fuel market expansion.

According to a Farmindustria data from 2016, Italy leads all EU countries in the export of medicines. Furthermore, job growth, together with R&D expenditure, is likely to propel the pharmaceutical industry forward over the projection period. This has the ability to propel the market forward in the next years.

• Asia Pacific

1. India

2. China

3. Japan

Adoption of functional foods and beverages is rising in the Asia-Pacific area, owing to rising disposable income and improved understanding of diverse nutritious goods and ingredients. Consumer demand for lucarnitine-containing foods and beverages is delivering significant benefits to the market as a whole. The heightened consumer interest in lucarnitine for health and health has been aided by ongoing research discovering its possible uses and health-promoting characteristics.

Carnitine Supplements Market Key Players:

1. Northeast Pharmaceutical Group Co., Ltd. (NEPG),

2. Lonza Group Ltd.

3. Ceva Santé Animale S.A.

4. Tokyo Chemical Industry Co., Ltd.

5. Kaiyuan Hengtai Chemical Co., Ltd

6. NOW Foods

7. Lamberts Healthcare

8. Bee Health

9. Kabco Pharmaceuticals

10. Optimum Nutrition